Literature DB >> 4856825

Serological evidence of infection by Pichinde virus among laboratory workers.

M Buchmeier, E Adam, W E Rawls.   

Abstract

A total of 44 laboratory workers were examined for serological evidence of infection by Pichinde virus. Complement-fixing antibodies were detected in the sera of 6 of 13 (46%) persons working with the virus but not among 31 persons not working with the virus. Serological evidence of infection was greatest among those workers exposed to concentrated virus. No distinct illness could be associated with the infection.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4856825      PMCID: PMC414891          DOI: 10.1128/iai.9.5.821-823.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  [Laboratory infections with the virus of lymphocytic choriomeningitis].

Authors:  W SCHEID; K A JOCHHEIM; W MOHR
Journal:  Dtsch Arch Klin Med       Date:  1956

2.  Measurement of antibodies to Machupo virus by the indirect fluorescent technique.

Authors:  C J Peters; P A Webb; K M Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1973-02

3.  Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings.

Authors:  J D Frame; J M Baldwin; D J Gocke; J M Troup
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

4.  Epidemiology of Machupo virus infection. 3. Significance of virological observations in man and animals.

Authors:  K M Johnson
Journal:  Am J Trop Med Hyg       Date:  1965-09       Impact factor: 2.345

5.  Pichindé virus, a new virus of the Tacaribe group from Colombia.

Authors:  H Trapido; C Sanmartín
Journal:  Am J Trop Med Hyg       Date:  1971-07       Impact factor: 2.345

6.  Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus.

Authors:  S M Buckley; J Casals
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

7.  Epidemic nonmeningitic lymphocytic-choriomeningitis-virus infection. An outbreak in a population of laboratory personnel.

Authors:  S G Baum; A M Lewis; W P Rowe; R J Huebner
Journal:  N Engl J Med       Date:  1966-04-28       Impact factor: 91.245

8.  Epidemiology of Machupo virus infection. II. Ecological and control studies of hemorrhagic fever.

Authors:  M L Kuns
Journal:  Am J Trop Med Hyg       Date:  1965-09       Impact factor: 2.345

9.  Isolation of Machupo virus from wild rodent Calomys callosus.

Authors:  K M Johnson; M L Kuns; R B Mackenzie; P A Webb; C E Yunker
Journal:  Am J Trop Med Hyg       Date:  1966-01       Impact factor: 2.345

10.  Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease.

Authors:  E Leifer; D J Gocke; H Bourne
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

View more
  13 in total

1.  Antigens of Pichinde virus I. Relationship of soluble antigens derived from infected BHK-21 cells to the structural components of the virion.

Authors:  M J Buchmeier; S R Gee; W E Rawls
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

2.  Role of natural killer cells in Pichinde virus infection of Syrian hamsters.

Authors:  S R Gee; M A Chan; D A Clark; W E Rawls
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

3.  A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.

Authors:  Jason Botten; J Lindsay Whitton; Polly Barrowman; John Sidney; Jason K Whitmire; Jeff Alexander; Maya F Kotturi; Alessandro Sette; Michael J Buchmeier
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

4.  Predictors of human-infective RNA virus discovery in the United States, China, and Africa, an ecological study.

Authors:  Feifei Zhang; Margo Chase-Topping; Chuan-Guo Guo; Mark E J Woolhouse
Journal:  Elife       Date:  2022-06-06       Impact factor: 8.713

5.  Variation between strains of hamsters in the lethality of Pichinde virus infections.

Authors:  M J Buchmeier; W E Rawls
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

6.  A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose.

Authors:  Rekha Dhanwani; Yanqin Zhou; Qinfeng Huang; Vikram Verma; Mythili Dileepan; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

7.  Review of Mammarenavirus Biology and Replication.

Authors:  Steven J Hallam; Takaaki Koma; Junki Maruyama; Slobodan Paessler
Journal:  Front Microbiol       Date:  2018-08-03       Impact factor: 5.640

Review 8.  Arenaviruses.

Authors:  J P Gonzalez; S Emonet; X de Lamballerie; R Charrel
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

Review 9.  Animal Models of Lassa Fever.

Authors:  Rachel A Sattler; Slobodan Paessler; Hinh Ly; Cheng Huang
Journal:  Pathogens       Date:  2020-03-06

10.  Virulent infection of outbred Hartley guinea pigs with recombinant Pichinde virus as a surrogate small animal model for human Lassa fever.

Authors:  Shuiyun Lan; Wun-Ju Shieh; Qinfeng Huang; Sherif R Zaki; Yuying Liang; Hinh Ly
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.